"Vitamin B12 (Cyanocobalamin)"
5.3 Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin Patients receiving MOUNJARO in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1), Drug Interactions (7.1)]
Drug-Drug Interactions: Methycobal 500 MCG Injection 5 x 1 ml may interact with anticancer medications (arsenic trioxide), antimetabolites (mercaptopurine), antibiotics (chloramphenicol), and oral contraceptives
Starting at lower dose ranges and titrating based on tolerability and response represents a conservative approach consistent with general peptide therapy principles
Each of us is differently affected and require a different frequency of B12 injections
Pinching the skin creates a fold that ensures subcutaneous rather than intramuscular injection